Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

Blood. 2009 Mar 19;113(12):2868-9; author reply 2869. doi: 10.1182/blood-2008-09-177733.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / etiology
  • Acute Lung Injury / mortality
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Child
  • Drug Therapy, Combination
  • Etanercept
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / mortality
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Kaplan-Meier Estimate
  • Pneumonia / drug therapy*
  • Pneumonia / etiology
  • Pneumonia / mortality
  • Prognosis
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Survival Rate
  • Syndrome
  • Transplantation, Homologous / adverse effects

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept